Compound details
Salutaridine
| Compound ID | CDAMM00558 |
|---|---|
| Common name | Salutaridine | IUPAC name | 3-hydroxy-4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5,10,13-pentaen-12-one |
| Molecular formula | C19H21NO4 |
| Retention time | 8.87 |
|---|---|
| Adduct | [2M+Na]+ |
| Actual mz | 677.276 | Theoretical mz | 677.283 |
| Error | 11.4 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.8072 |
| Inchi key | GVTRUVGBZQJVTF-KINVLMLONA-N |
|---|---|
| Smiles | O=C1C=C2C3N(C)CCC2(C=C1OC)C4=C(O)C(OC)=CC=C4C3 |
| Superclass | Benzenoids |
| Class | Phenanthrenes and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| Q9Y5N1 | HRH3 | Histamine H3 receptor | T64765 | SwissTargetPrediction |
| P08173 | CHRM4 | Muscarinic acetylcholine receptor M4 | T20709 | SwissTargetPrediction |
| P08912 | CHRM5 | Muscarinic acetylcholine receptor M5 | T79961 | SwissTargetPrediction |
| Q12809 | KCNH2 | HERG | T20251 | SwissTargetPrediction |
| P20309 | CHRM3 | Muscarinic acetylcholine receptor M3 | T67684 | SwissTargetPrediction |
| P10635 | CYP2D6 | Cytochrome P450 2D6 | T57392 | SwissTargetPrediction |
| Q16790 | CA9 | Carbonic anhydrase IX | T64567 | SwissTargetPrediction |
| P29475 | NOS1 | Nitric-oxide synthase, brain | T16117 | SwissTargetPrediction |
| P35228 | NOS2 | Nitric oxide synthase, inducible | T02703 | SwissTargetPrediction |
| P09960 | LTA4H | Leukotriene A4 hydrolase | T03691 | SwissTargetPrediction |
| P0DMS8 | ADORA3 | Adenosine A3 receptor | T36059 | SwissTargetPrediction |
| P21397 | MAOA | Monoamine oxidase A | T83875 | SwissTargetPrediction |
| P00915 | CA1 | Carbonic anhydrase I | T13201 | SwissTargetPrediction |
| P00918 | CA2 | Carbonic anhydrase II | T20401 | SwissTargetPrediction |
| P16083 | NQO2 | Quinone reductase 2 | T75498 | SwissTargetPrediction |
| P98170 | XIAP | Inhibitor of apoptosis protein 3 | T16769 | SwissTargetPrediction |
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SwissTargetPrediction |
| P27338 | MAOB | Monoamine oxidase B | T83011 | SwissTargetPrediction |
| O60341 | KDM1A | Lysine-specific histone demethylase 1 | T16739 | SwissTargetPrediction |
| P28335 | HTR2C | Serotonin 2c (5-HT2c) receptor | T83813 | SwissTargetPrediction |
| P41595 | HTR2B | Serotonin 2b (5-HT2b) receptor | T31204 | SwissTargetPrediction |
| P28221 | HTR1D | Serotonin 1d (5-HT1d) receptor | T11072 | SwissTargetPrediction |
| P34969 | HTR7 | Serotonin 7 (5-HT7) receptor | T79062 | SwissTargetPrediction |
| P50406 | HTR6 | Serotonin 6 (5-HT6) receptor | T16691 | SwissTargetPrediction |
| P24864 | CCNE1 | Cyclin-dependent kinase 2/cyclin E1 | T10052 | SwissTargetPrediction |
| P05164 | MPO | Myeloperoxidase | T23471 | SwissTargetPrediction |
| Q99705 | MCHR1 | Melanin-concentrating hormone receptor 1 | T09572 | SwissTargetPrediction |
| P45983 | MAPK8 | c-Jun N-terminal kinase 1 | T40097 | SwissTargetPrediction |
| Q9H3N8 | HRH4 | Histamine H4 receptor | T26500 | SwissTargetPrediction |
| P25021 | HRH2 | Histamine H2 receptor | T30985 | SwissTargetPrediction |
| P35367 | HRH1 | Histamine H1 receptor | T77913 | SwissTargetPrediction |
| P21918 | DRD5 | Dopamine D5 receptor | T46828 | SwissTargetPrediction |
| P23975 | SLC6A2 | Norepinephrine transporter | T21945 | SwissTargetPrediction |
| P35372 | OPRM1 | Mu opioid receptor | T47768 | SwissTargetPrediction and SEA |
| P25100 | ADRA1D | Alpha-1d adrenergic receptor | T53381 | SwissTargetPrediction |
| P41145 | OPRK1 | Kappa Opioid receptor | T60693 | SwissTargetPrediction and SEA |
| O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | T62449 | SwissTargetPrediction |
| O60674 | JAK2 | Tyrosine-protein kinase JAK2 | T08391 | SwissTargetPrediction |
| Q9Y233 | PDE10A | Phosphodiesterase 10A (by homology) | T84133 | SwissTargetPrediction |
| P35270 | SPR | Substance-P receptor | T47094 | SwissTargetPrediction |
| P32245 | MC4R | Melanocortin receptor 4 | T72458 | SwissTargetPrediction |
| P41143 | OPRD1 | Delta opioid receptor | T58992 | SwissTargetPrediction and SEA |
| Q13490 | BIRC2 | Baculoviral IAP repeat-containing protein 2 | T84780 | SwissTargetPrediction |
| P24723 | PRKCH | Protein kinase C eta | T40149 | SwissTargetPrediction |
| Q9UHL4 | DPP7 | Dipeptidyl peptidase II | T50773 | SwissTargetPrediction |
| O75116 | ROCK2 | Rho-associated protein kinase 2 | T06093 | SwissTargetPrediction |
| P23458 | JAK1 | Tyrosine-protein kinase JAK1 | T62460 | SwissTargetPrediction |
| P49841 | GSK3B | Glycogen synthase kinase-3 beta | T70977 | SwissTargetPrediction |
| Q02156 | PRKCE | Protein kinase C epsilon | T00895 | SwissTargetPrediction |
| P08581 | MET | Hepatocyte growth factor receptor | T40474 | SwissTargetPrediction |
| P30411 | BDKRB2 | Bradykinin B2 receptor | T23714 | SwissTargetPrediction |
| Q12884 | FAP | Fibroblast activation protein alpha (by homology) | T53764 | SwissTargetPrediction |
| P52333 | JAK3 | Tyrosine-protein kinase JAK3 | T23172 | SwissTargetPrediction |
| P29597 | TYK2 | Tyrosine-protein kinase TYK2 | T78932 | SwissTargetPrediction |
| P48039 | MTNR1A | Melatonin receptor 1A | T97613 | SwissTargetPrediction |
| P49286 | MTNR1B | Melatonin receptor 1B | T48268 | SwissTargetPrediction |
| Q05655 | PRKCD | Protein kinase C delta | T44861 | SwissTargetPrediction |
| P07333 | CSF1R | Macrophage colony stimulating factor receptor | T20333 | SwissTargetPrediction |
| P35346 | SSTR5 | Somatostatin receptor 5 | T64830 | SwissTargetPrediction |
| P46098 | HTR3A | Serotonin 3a (5-HT3a) receptor | T64591 | SwissTargetPrediction |
| P31391 | SSTR4 | Somatostatin receptor 4 | T62974 | SwissTargetPrediction |
| P30872 | SSTR1 | Somatostatin receptor 1 | T16633 | SwissTargetPrediction |
| P19793 | RXRA | Retinoid X receptor alpha (by homology) | T13726 | SwissTargetPrediction |
| Q13976 | PRKG1 | cGMP-dependent protein kinase 1 beta | T78543 | SwissTargetPrediction |
| Q04759 | PRKCQ | Protein kinase C theta | T23995 | SwissTargetPrediction |
| P68400 | CSNK2A1 | Casein kinase II alpha | T51565 | SwissTargetPrediction |
| Q6V1X1 | DPP8 | Dipeptidyl peptidase VIII | T15855 | SwissTargetPrediction |
| Q86TI2 | DPP9 | Dipeptidyl peptidase IX | T66252 | SwissTargetPrediction |
| P19784 | CSNK2A2 | Casein kinase II alpha (prime) | T80526 | SwissTargetPrediction |
| Q14680 | MELK | Maternal embryonic leucine zipper kinase | T96892 | SwissTargetPrediction |
| Q13464 | ROCK1 | Rho-associated protein kinase 1 | T51282 | SwissTargetPrediction |
| Q96KB5 | PBK | PDZ-binding kinase | T98642 | SwissTargetPrediction |
| Q99873 | PRMT1 | Protein-arginine N-methyltransferase 1 | T16808 | SwissTargetPrediction |
| P15559 | NQO1 | Quinone reductase 1 | T52389 | SwissTargetPrediction |
| P30939 | HTR1F | Serotonin 1f (5-HT1f) receptor | T78656 | SwissTargetPrediction |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T64765 | DI0392 | Somnolence | [ICD-11: MG42] | Q9Y5N1 | HRH3 |
| T20709 | DI0037 | Asthma | [ICD-11: CA23] | P08173 | CHRM4 |
| T20709 | DI0141 | Eye anterior segment structural developmental anomaly | [ICD-11: LA11] | P08173 | CHRM4 |
| T20709 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08173 | CHRM4 |
| T20709 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P08173 | CHRM4 |
| T20709 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P08173 | CHRM4 |
| T79961 | DI0002 | Abnormal micturition | [ICD-11: MF50] | P08912 | CHRM5 |
| T79961 | DI0032 | Anterior uveitis | [ICD-11: 9A96] | P08912 | CHRM5 |
| T79961 | DI0034 | Appearance/behaviour symptom | [ICD-11: MB23] | P08912 | CHRM5 |
| T79961 | DI0037 | Asthma | [ICD-11: CA23] | P08912 | CHRM5 |
| T79961 | DI0061 | Brain disease | [ICD-11: 8C70-8E61] | P08912 | CHRM5 |
| T79961 | DI0071 | Central and peripheral nervous disease | [ICD-11: 8A04-8E7Z] | P08912 | CHRM5 |
| T79961 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P08912 | CHRM5 |
| T79961 | DI0093 | Cognition symptoms/signs/clinical symptom | [ICD-11: MB21] | P08912 | CHRM5 |
| T79961 | DI0105 | Cough | [ICD-11: MD12] | P08912 | CHRM5 |
| T79961 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P08912 | CHRM5 |
| T79961 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P08912 | CHRM5 |
| T79961 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P08912 | CHRM5 |
| T79961 | DI0158 | Gastritis | [ICD-11: DA42] | P08912 | CHRM5 |
| T79961 | DI0162 | General examination | [ICD-11: QA00] | P08912 | CHRM5 |
| T79961 | DI0166 | Glaucoma | [ICD-11: 9C61] | P08912 | CHRM5 |
| T79961 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P08912 | CHRM5 |
| T79961 | DI0208 | Infectious gastroenteritis/colitis | [ICD-11: 1A40] | P08912 | CHRM5 |
| T79961 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P08912 | CHRM5 |
| T79961 | DI0307 | Nystagmus | [ICD-11: 9C84] | P08912 | CHRM5 |
| T79961 | DI0315 | Oesophagus motility disorder | [ICD-11: DA21] | P08912 | CHRM5 |
| T79961 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P08912 | CHRM5 |
| T79961 | DI0329 | Pancreatitis | [ICD-11: DC31-DC34] | P08912 | CHRM5 |
| T79961 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P08912 | CHRM5 |
| T79961 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P08912 | CHRM5 |
| T79961 | DI0338 | Polyuria | [ICD-11: MF55] | P08912 | CHRM5 |
| T79961 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P08912 | CHRM5 |
| T79961 | DI0421 | Unspecific substance harmful effect | [ICD-11: NE6Z] | P08912 | CHRM5 |
| T79961 | DI0424 | Urgency | [ICD-11: N.A.] | P08912 | CHRM5 |
| T20251 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | Q12809 | KCNH2 |
| T67684 | DI0037 | Asthma | [ICD-11: CA23] | P20309 | CHRM3 |
| T67684 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P20309 | CHRM3 |
| T67684 | DI0154 | Functional bladder disorder | [ICD-11: GC50] | P20309 | CHRM3 |
| T67684 | DI0166 | Glaucoma | [ICD-11: 9C61] | P20309 | CHRM3 |
| T67684 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P20309 | CHRM3 |
| T67684 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P20309 | CHRM3 |
| T67684 | DI0362 | Respiratory system disease | [ICD-11: CB40-CB7Z] | P20309 | CHRM3 |
| T67684 | DI0371 | Sebaceous gland disorder | [ICD-11: ED91] | P20309 | CHRM3 |
| T67684 | DI0382 | Sjogren syndrome | [ICD-11: 4A43] | P20309 | CHRM3 |
| T67684 | DI0411 | Tonus and reflex abnormality | [ICD-11: MB47] | P20309 | CHRM3 |
| T57392 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P10635 | CYP2D6 |
| T64567 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16790 | CA9 |
| T16117 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P29475 | NOS1 |
| T16117 | DI0264 | Migraine | [ICD-11: 8A80] | P29475 | NOS1 |
| T02703 | DI0083 | Chronic kidney disease | [ICD-11: GB61] | P35228 | NOS2 |
| T02703 | DI0320 | Osteoarthritis | [ICD-11: FA00-FA05] | P35228 | NOS2 |
| T02703 | DI0375 | Sepsis | [ICD-11: 1G40-1G41] | P35228 | NOS2 |
| T02703 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P35228 | NOS2 |
| T03691 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P09960 | LTA4H |
| T36059 | DI0351 | Psoriasis | [ICD-11: EA90] | P0DMS8 | ADORA3 |
| T36059 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P0DMS8 | ADORA3 |
| T83875 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P21397 | MAOA |
| T83875 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21397 | MAOA |
| T13201 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00915 | CA1 |
| T13201 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00915 | CA1 |
| T20401 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P00918 | CA2 |
| T20401 | DI0137 | Essential hypertension | [ICD-11: BA00] | P00918 | CA2 |
| T20401 | DI0166 | Glaucoma | [ICD-11: 9C61] | P00918 | CA2 |
| T20401 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P00918 | CA2 |
| T20401 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P00918 | CA2 |
| T20401 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P00918 | CA2 |
| T75498 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P16083 | NQO2 |
| T16769 | DI0259 | Metastatic lymph node neoplasm | [ICD-11: 2D60] | P98170 | XIAP |
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T83011 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | P27338 | MAOB |
| T83011 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P27338 | MAOB |
| T83011 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P27338 | MAOB |
| T83011 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P27338 | MAOB |
| T83011 | DI0264 | Migraine | [ICD-11: 8A80] | P27338 | MAOB |
| T83011 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P27338 | MAOB |
| T16739 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | O60341 | KDM1A |
| T16739 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | O60341 | KDM1A |
| T16739 | DI0138 | Ewing sarcoma | [ICD-11: 2B52] | O60341 | KDM1A |
| T16739 | DI0238 | Lung cancer | [ICD-11: 2C25] | O60341 | KDM1A |
| T16739 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O60341 | KDM1A |
| T16739 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O60341 | KDM1A |
| T16739 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | O60341 | KDM1A |
| T16739 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | O60341 | KDM1A |
| T16739 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O60341 | KDM1A |
| T83813 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P28335 | HTR2C |
| T83813 | DI0264 | Migraine | [ICD-11: 8A80] | P28335 | HTR2C |
| T83813 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P28335 | HTR2C |
| T83813 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P28335 | HTR2C |
| T83813 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28335 | HTR2C |
| T31204 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P41595 | HTR2B |
| T31204 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P41595 | HTR2B |
| T31204 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P41595 | HTR2B |
| T31204 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P41595 | HTR2B |
| T11072 | DI0264 | Migraine | [ICD-11: 8A80] | P28221 | HTR1D |
| T11072 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P28221 | HTR1D |
| T79062 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P34969 | HTR7 |
| T79062 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P34969 | HTR7 |
| T79062 | DI0051 | Bipolar disorder | [ICD-11: 6A60] | P34969 | HTR7 |
| T79062 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P34969 | HTR7 |
| T79062 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P34969 | HTR7 |
| T79062 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P34969 | HTR7 |
| T79062 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P34969 | HTR7 |
| T16691 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P50406 | HTR6 |
| T16691 | DI0370 | Schizophrenia | [ICD-11: 6A20] | P50406 | HTR6 |
| T23471 | DI0229 | Left ventricular failure | [ICD-11: BD11] | P05164 | MPO |
| T23471 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P05164 | MPO |
| T09572 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q99705 | MCHR1 |
| T40097 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P45983 | MAPK8 |
| T26500 | DI0037 | Asthma | [ICD-11: CA23] | Q9H3N8 | HRH4 |
| T26500 | DI0039 | Atopic eczema | [ICD-11: EA80] | Q9H3N8 | HRH4 |
| T26500 | DI0351 | Psoriasis | [ICD-11: EA90] | Q9H3N8 | HRH4 |
| T26500 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9H3N8 | HRH4 |
| T26500 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q9H3N8 | HRH4 |
| T30985 | DI0161 | Gastro-oesophageal reflux disease | [ICD-11: DA22] | P25021 | HRH2 |
| T30985 | DI0313 | Oesophageal/gastroduodenal disorder | [ICD-11: DD90] | P25021 | HRH2 |
| T30985 | DI0333 | Peptic ulcer | [ICD-11: DA61] | P25021 | HRH2 |
| T77913 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P35367 | HRH1 |
| T77913 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | P35367 | HRH1 |
| T77913 | DI0063 | Breathing abnormality | [ICD-11: MD11] | P35367 | HRH1 |
| T77913 | DI0099 | Conjunctiva disorder | [ICD-11: 9A60] | P35367 | HRH1 |
| T77913 | DI0105 | Cough | [ICD-11: MD12] | P35367 | HRH1 |
| T77913 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35367 | HRH1 |
| T77913 | DI0136 | Episodic vestibular syndrome | [ICD-11: AB31] | P35367 | HRH1 |
| T77913 | DI0173 | Headache | [ICD-11: 8A80-8A84] | P35367 | HRH1 |
| T77913 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P35367 | HRH1 |
| T77913 | DI0272 | Morning sickness disorder | [ICD-11: SC00] | P35367 | HRH1 |
| T77913 | DI0292 | Nasopharyngitis | [ICD-11: CA00] | P35367 | HRH1 |
| T77913 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P35367 | HRH1 |
| T77913 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P35367 | HRH1 |
| T77913 | DI0349 | Pruritus | [ICD-11: EC90] | P35367 | HRH1 |
| T77913 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P35367 | HRH1 |
| T77913 | DI0388 | Sleep-wake disorder | [ICD-11: 7A00-7B2Z] | P35367 | HRH1 |
| T77913 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | P35367 | HRH1 |
| T46828 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21918 | DRD5 |
| T21945 | DI0013 | Acute pain | [ICD-11: MG31] | P23975 | SLC6A2 |
| T21945 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P23975 | SLC6A2 |
| T21945 | DI0087 | Chronic pain | [ICD-11: MG30] | P23975 | SLC6A2 |
| T21945 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P23975 | SLC6A2 |
| T21945 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P23975 | SLC6A2 |
| T21945 | DI0166 | Glaucoma | [ICD-11: 9C61] | P23975 | SLC6A2 |
| T21945 | DI0264 | Migraine | [ICD-11: 8A80] | P23975 | SLC6A2 |
| T21945 | DI0301 | Nicotine use disorder | [ICD-11: 6C4A] | P23975 | SLC6A2 |
| T21945 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P23975 | SLC6A2 |
| T21945 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P23975 | SLC6A2 |
| T21945 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P23975 | SLC6A2 |
| T47768 | DI0013 | Acute pain | [ICD-11: MG31] | P35372 | OPRM1 |
| T47768 | DI0059 | Bowel habit change | [ICD-11: ME05] | P35372 | OPRM1 |
| T47768 | DI0087 | Chronic pain | [ICD-11: MG30] | P35372 | OPRM1 |
| T47768 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P35372 | OPRM1 |
| T47768 | DI0105 | Cough | [ICD-11: MD12] | P35372 | OPRM1 |
| T47768 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35372 | OPRM1 |
| T47768 | DI0124 | Digestive system disease | [ICD-11: DE2Z] | P35372 | OPRM1 |
| T47768 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P35372 | OPRM1 |
| T47768 | DI0228 | Large intestine motility disorder | [ICD-11: DB32] | P35372 | OPRM1 |
| T47768 | DI0317 | Opioid use disorder | [ICD-11: 6C43] | P35372 | OPRM1 |
| T47768 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P35372 | OPRM1 |
| T47768 | DI0349 | Pruritus | [ICD-11: EC90] | P35372 | OPRM1 |
| T47768 | DI0374 | Sensation disturbance | [ICD-11: MB40] | P35372 | OPRM1 |
| T53381 | DI0166 | Glaucoma | [ICD-11: 9C61] | P25100 | ADRA1D |
| T53381 | DI0175 | Heart failure | [ICD-11: BD10-BD1Z] | P25100 | ADRA1D |
| T53381 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P25100 | ADRA1D |
| T53381 | DI0348 | Prostate hyperplasia | [ICD-11: GA90] | P25100 | ADRA1D |
| T53381 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P25100 | ADRA1D |
| T53381 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P25100 | ADRA1D |
| T60693 | DI0304 | Non-specific cutaneous vascular symptom | [ICD-11: ME64] | P41145 | OPRK1 |
| T60693 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41145 | OPRK1 |
| T60693 | DI0349 | Pruritus | [ICD-11: EC90] | P41145 | OPRK1 |
| T62449 | DI0027 | Anal cancer | [ICD-11: 2C00] | O14757 | CHEK1 |
| T62449 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | O14757 | CHEK1 |
| T62449 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | O14757 | CHEK1 |
| T62449 | DI0238 | Lung cancer | [ICD-11: 2C25] | O14757 | CHEK1 |
| T62449 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O14757 | CHEK1 |
| T62449 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O14757 | CHEK1 |
| T62449 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14757 | CHEK1 |
| T62449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14757 | CHEK1 |
| T08391 | DI0039 | Atopic eczema | [ICD-11: EA80] | O60674 | JAK2 |
| T08391 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | O60674 | JAK2 |
| T08391 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | O60674 | JAK2 |
| T08391 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | O60674 | JAK2 |
| T84133 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | Q9Y233 | PDE10A |
| T84133 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | Q9Y233 | PDE10A |
| T84133 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | Q9Y233 | PDE10A |
| T84133 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q9Y233 | PDE10A |
| T84133 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9Y233 | PDE10A |
| T47094 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35270 | SPR |
| T47094 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P35270 | SPR |
| T72458 | DI0192 | Hypoactive sexual desire dysfunction | [ICD-11: HA00] | P32245 | MC4R |
| T72458 | DI0228 | Large intestine motility disorder | [ICD-11: DB32] | P32245 | MC4R |
| T72458 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P32245 | MC4R |
| T58992 | DI0059 | Bowel habit change | [ICD-11: ME05] | P41143 | OPRD1 |
| T58992 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P41143 | OPRD1 |
| T58992 | DI0324 | Pain | [ICD-11: MG30-MG3Z] | P41143 | OPRD1 |
| T84780 | DI0259 | Metastatic lymph node neoplasm | [ICD-11: 2D60] | Q13490 | BIRC2 |
| T40149 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P24723 | PRKCH |
| T06093 | DI0168 | Graft-versus-host disease | [ICD-11: 4B24] | O75116 | ROCK2 |
| T62460 | DI0039 | Atopic eczema | [ICD-11: EA80] | P23458 | JAK1 |
| T62460 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P23458 | JAK1 |
| T62460 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P23458 | JAK1 |
| T62460 | DI0404 | Thrombocytosis | [ICD-11: 3B63] | P23458 | JAK1 |
| T70977 | DI0288 | Myotonic disorder | [ICD-11: 8C71] | P49841 | GSK3B |
| T00895 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | Q02156 | PRKCE |
| T00895 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | Q02156 | PRKCE |
| T40474 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P08581 | MET |
| T40474 | DI0407 | Thyroid cancer | [ICD-11: 2D10] | P08581 | MET |
| T23714 | DI0213 | Innate/adaptive immunodeficiency | [ICD-11: 4A00] | P30411 | BDKRB2 |
| T53764 | DI0300 | Neutropenia | [ICD-11: 4B00] | Q12884 | FAP |
| T23172 | DI0023 | Alopecia | [ICD-11: ED70] | P52333 | JAK3 |
| T23172 | DI0039 | Atopic eczema | [ICD-11: EA80] | P52333 | JAK3 |
| T23172 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P52333 | JAK3 |
| T23172 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P52333 | JAK3 |
| T78932 | DI0351 | Psoriasis | [ICD-11: EA90] | P29597 | TYK2 |
| T97613 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P48039 | MTNR1A |
| T48268 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P49286 | MTNR1B |
| T44861 | DI0287 | Myocardial infarction | [ICD-11: BA41-BA43] | Q05655 | PRKCD |
| T20333 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P07333 | CSF1R |
| T64830 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P35346 | SSTR5 |
| T64591 | DI0087 | Chronic pain | [ICD-11: MG30] | P46098 | HTR3A |
| T64591 | DI0101 | Corneal disease | [ICD-11: 9A76-9A78] | P46098 | HTR3A |
| T64591 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P46098 | HTR3A |
| T64591 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P46098 | HTR3A |
| T64591 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P46098 | HTR3A |
| T62974 | DI0087 | Chronic pain | [ICD-11: MG30] | P31391 | SSTR4 |
| T62974 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P31391 | SSTR4 |
| T16633 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P30872 | SSTR1 |
| T16633 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P30872 | SSTR1 |
| T13726 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P19793 | RXRA |
| T13726 | DI0283 | Mycosis fungoides | [ICD-11: 2B01] | P19793 | RXRA |
| T23995 | DI0413 | Transplant rejection | [ICD-11: NE84] | Q04759 | PRKCQ |
| T51565 | DI0104 | Coronavirus infection | [ICD-11: 1D92] | P68400 | CSNK2A1 |
| T51565 | DI0235 | Liver cancer | [ICD-11: 2C12] | P68400 | CSNK2A1 |
| T51565 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P68400 | CSNK2A1 |
| T15855 | DI0300 | Neutropenia | [ICD-11: 4B00] | Q6V1X1 | DPP8 |
| T66252 | DI0300 | Neutropenia | [ICD-11: 4B00] | Q86TI2 | DPP9 |
| T96892 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q14680 | MELK |
| T96892 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q14680 | MELK |
| T96892 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | Q14680 | MELK |
| T96892 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q14680 | MELK |
| T96892 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | Q14680 | MELK |
| T96892 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | Q14680 | MELK |
| T51282 | DI0166 | Glaucoma | [ICD-11: 9C61] | Q13464 | ROCK1 |
| T98642 | DI0291 | Nasopharyngeal cancer | [ICD-11: 2B6B] | Q96KB5 | PBK |
| T16808 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q99873 | PRMT1 |
| T52389 | DI0079 | Choreiform disorder | [ICD-11: 8A01] | P15559 | NQO1 |
| T52389 | DI0090 | CNS anomalies syndrome | [ICD-11: LD20] | P15559 | NQO1 |
| T52389 | DI0202 | Inborn energy metabolism error | [ICD-11: 5C53] | P15559 | NQO1 |
| T52389 | DI0215 | Intellectual development disorder | [ICD-11: LD90] | P15559 | NQO1 |
| T52389 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P15559 | NQO1 |
| T52389 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P15559 | NQO1 |
| T78656 | DI0264 | Migraine | [ICD-11: 8A80] | P30939 | HTR1F |
| T78656 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P30939 | HTR1F |